Growing Evidence for an Underestimation of Poor-Risk Cytogenetics in the International Prognostic Scoring System in Myelodysplastic Syndromes-Reference-Cited by-同舟云学术

Growing Evidence for an Underestimation of Poor-Risk Cytogenetics in the International Prognostic Scoring System in Myelodysplastic Syndromes

Published:2007-12 Issue:6 Volume:1 Page:353-356
ISSN:1931-6925
Container-title:Clinical Leukemia
language:en
Short-container-title:Clinical Leukemia

Author:

Steidl Christian,Schanz Julie,Pfeilstöcker Michael,Nösslinger Thomas,Hildebrandt Barbara,Kuendgen Andrea,Lübbert Michael,Kunzmann Regina,Giagounidis Aristoteles,Aul Carlo,Trümper Lorenz,Krieger Otto,Stauder Reinhard,Müller Thomas H.,Wimazal Friedrich,Valent Peter,Fonatsch Christa,Germing Ulrich,Haase Detlef

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Proposals for the classification of the myelodysplastic syndromes;Bennett;Br J Haematol,1982

2. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS;Tricot;Br J Haematol,1984

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS);Germing;Leukemia,2005

5. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes;Sole;Haematologica,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic Syndromes;Leukemia Research;2012-02

2. Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System;Journal of Clinical Oncology;2011-05-20

3. Prognostic Scoring in MDS;The Myelodysplastic Syndromes;2011

4. Cytogenetics of MDS;The Myelodysplastic Syndromes;2011

5. Die individualisierte Riskoeinschätzung und Therapieplanung bei myelodysplastischen Syndromen;Wiener klinische Wochenschrift;2008-09